Bottle Label 5 mg (71610 0503 60)
Terazosin Capsule
Product Images NDC 71610-510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle Label 2 mg (71610 0510 30)
Aphena Pharma Solutions (TN)
Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Figure 1 (Terazosin Hydrochloride Capsules 2)
Figure 2 (Terazosin Hydrochloride Capsules 3)
The provided text is a tabular format indicating the mean change from the baseline for different time intervals of 7 months, starting from month 0 to month 30, at an interval of 3 months.*
Figure 3 (Terazosin Hydrochloride Capsules 4)
Data appears to be a chart or graph with measurements in mL/sec taken over a period of time from Month 0 to Month 30. Without additional context or labels, it is difficult to determine the exact nature or significance of the data.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
